What was recalled
The U.S. Food and Drug Administration (FDA) has announced a Class II recall involving specific units of the KidneyVault Portable Renal Perfusion System, a medical device manufactured by Paragonix Technologies Inc. This recall centers on a specialized piece of equipment designed to preserve kidneys during transport, ensuring they remain viable for transplantation. The product in question is identified under the brand name Paragonix, with the specific model reference number PRGNX-8008-001. It is crucial to note that this action does not apply to all devices made by Paragonix Technologies Inc., but is strictly limited to those units falling within the precise specifications outlined below.
The affected inventory includes every unit of the KidneyVault Portable Renal Perfusion System manufactured with software version Paragonix App Ver. 6.1.1 or 6.1.2. The scope of this recall covers all serial numbers and Unique Device Identifiers (UDI) associated with the specific UDI string 00850005470342. If you are a healthcare provider, hospital administrator, or transplant coordinator who received this device, you must verify the software version and serial number against these criteria to determine if your unit is part of this recall batch.
This medical device was distributed nationwide across the United States, covering numerous states and territories. The distribution pattern includes devices sold or delivered to locations in Alabama (AL), Arizona (AZ), California (CA), Tennessee (TN), Florida (FL), Hawaii (HI), Minnesota (MN), New Jersey (NJ), Texas (TX), Utah (UT), Colorado (CO), Connecticut (CT), the District of Columbia (DC), Maryland (MD), Georgia (GA), Kentucky (KY), Louisiana (LA), Massachusetts (MA), Michigan (MI), Missouri (MO), Mississippi (MS), North Carolina (NC), North Dakota (ND), Nebraska (NE), New Mexico (NM), Nevada (NV), New York (NY), Pennsylvania (PA), Puerto Rico (PR), South Carolina (SC), Virginia (VA), Wisconsin (WI), West Virginia (WV), Indiana (IN), Ohio (OH), Illinois (IL), and Oregon (OR). The recall was officially initiated on July 20, 2026, marking the date when Paragonix Technologies Inc. began the process of notifying customers and regulatory bodies.
While the FDA classifies this as a Class II recall, indicating that use of the device may cause temporary or medically reversible health consequences, the company has not yet stated a specific remedy in the initial report. This means there is no immediate instruction for repair, replacement, or refund available at this time. However, the identification of the product, its software versions, and its widespread distribution pattern provides a clear picture of which facilities are potentially impacted. Healthcare providers should immediately audit their inventory against the specified reference number PRGNX-8008-001 and the listed software versions to ensure patient safety protocols are maintained during this interim period.
The hazard, explained
At the heart of this FDA Class II recall is a subtle but critical failure in the software that guides the Paragonix KidneyVault Portable Renal Perfusion System (REF# PRGNX-8008-001). Specifically, the issue lies within the device’s datalogger firmware, particularly for units running Paragonix App Ver. 6.1.1 or 6.1.2. To understand why this matters, it helps to look at what the device is actually doing. The KidneyVault is not just a cooler; it is an active life-support system designed to keep a donated kidney warm and flowing with nutrient-rich solution while it travels from the donor hospital to the transplant center. During this transport, the organ is completely dependent on the machine’s precise monitoring of temperature, pressure, and flow rates. These parameters are displayed on the screen so that medical professionals can verify the organ is being preserved correctly.
The defect described in the recall notice indicates a firmware error that causes the device to lose its configuration unexpectedly. In practical terms, this means the screen may go blank or fail to display the vital preservation parameters that clinicians rely on. While the hardware might continue to pump solution, the loss of visual data creates a dangerous blind spot. Medical staff can no longer confirm in real-time if the kidney is being kept at the correct temperature or if the perfusion pressure remains within safe limits. This is not merely an inconvenience; it is a breakdown in the feedback loop that ensures organ viability.
Why is this so serious? Kidneys are highly sensitive to changes in temperature and oxygenation. If the machine malfunctions silently—because the screen cannot show the error or the current status—the organ could be exposed to damaging conditions without anyone realizing it. For example, if the cooling mechanism fails but the screen remains blank, the kidney could warm up beyond safe thresholds, leading to tissue damage. Similarly, if perfusion pressure drops too low, blood flow stops, causing ischemic injury to the organ cells. In either scenario, the transplanted kidney might fail after surgery, necessitating immediate dialysis or even a second transplant, which carries significant health risks and emotional toll for the patient.
It is important to note that this hazard is classified as Class II by the FDA, which typically denotes a condition that is temporary or medically reversible but poses a serious risk if left unaddressed. The recall affects devices distributed nationwide, including in Massachusetts, where all serial numbers and UDI codes associated with this software version are implicated. Because the failure is rooted in the datalogger’s ability to retain its settings, it can occur without any prior warning signs from the user. This unpredictability is what makes the recall necessary: you cannot rely on visual cues to know if the device is functioning correctly when the screen itself is part of the problem.
In summary, the physical mechanism at fault is a software configuration loss that leads to a blank or non-responsive display. The resulting harm stems from the inability of medical staff to monitor critical preservation parameters, potentially allowing an organ to be damaged during transport before it ever reaches the patient. This underscores the importance of immediate action for anyone in possession of this specific device model.
Who is most at risk
To understand who is truly at risk with the recall of the Paragonix KidneyVault Portable Renal Perfusion System (REF# PRGNX-8008-001), it is essential to first clarify that this is not a consumer product found in household kitchens or garages. This is a specialized, Class II medical device designed specifically for clinical and transplant center environments. Therefore, the "users" at risk are primarily healthcare professionals—surgeons, nurses, perfusionists, and organ procurement organization staff—who rely on this technology to maintain the viability of donor kidneys during transport. The individuals most vulnerable to the consequences of this device failure are not the patients in the operating room at this exact moment, but rather the potential transplant recipients who depend on the successful delivery of these organs.
The core of the risk lies in the nature of the hazard: a firmware defect that causes the datalogger to lose its configuration, resulting in a blank screen and the loss of displayed preservation parameters. For a layperson, a blank screen might seem like an inconvenience. For a transplant team, it is a critical failure point. The KidneyVault system monitors and maintains the specific conditions necessary to keep a donor kidney alive outside the body. If the screen goes blank, the medical staff loses real-time visibility into crucial data such as temperature, pressure, and flow rates. This creates a scenario where the device may appear to be functioning normally while silently failing to preserve the organ correctly. The risk is not immediate physical harm from an explosion or electrical shock, but rather the silent degradation of the organ.
The people most at risk are therefore the recipients waiting for these kidneys. If the preservation parameters are lost or incorrect due to the blank screen, the kidney may suffer irreversible damage before it is even implanted. This could lead to delayed graft function, where the new kidney does not work immediately after surgery, potentially requiring dialysis for an extended period. In severe cases, the organ may be deemed unusable entirely, meaning a life-saving gift is lost. For elderly patients or those with complex comorbidities already on the transplant waiting list, the loss of a matched organ can mean a longer wait time and increased health deterioration while they continue to search for a viable donor.
Additionally, healthcare institutions in the distribution states—Alabama, Arizona, California, Tennessee, Florida, Hawaii, Minnesota, New Jersey, Texas, Utah, Colorado, Connecticut, the District of Columbia, Maryland, Georgia, Kentucky, Louisiana, Massachusetts, Michigan, Missouri, Mississippi, North Carolina, North Dakota, Nebraska, New Mexico, Nevada, New York, Pennsylvania, Puerto Rico, South Carolina, Virginia, Wisconsin, West Virginia, Indiana, Ohio, Illinois, and Oregon—are at operational risk. These facilities must now halt the use of affected units (Software Version Paragonix App Ver. 6.1.1/6.1.2, Serial Numbers starting with 00850005470342) to verify their status. The burden falls on these medical teams to identify potentially compromised devices and ensure they do not inadvertently use a unit that could jeopardize patient outcomes.
In summary, while the device itself does not pose a direct physical threat to users through mechanical failure, the risk is profound in its potential to compromise the integrity of life-saving medical treatments. The vulnerability extends from the clinical staff who must manage the uncertainty of the device's performance to the patients whose lives depend on the precise function of this technology.
How to tell if you have the recalled item
If you or a medical facility you are associated with possesses equipment from Paragonix Technologies Inc., verifying whether your specific unit is part of this recall requires careful attention to precise technical details. Because this is a specialized medical device used for organ preservation, identification relies on exact model numbers, software versions, and unique identifiers rather than general appearance. Please take the time to locate the physical label on the KidneyVault Portable Renal Perfusion System. This label is typically affixed to the main body of the unit and serves as the primary source of truth for your device’s identity.
The first critical piece of information to verify is the Reference Number, often abbreviated as REF. You must confirm that the number printed on your device matches PRGNX-8008-001. If your unit has a different reference number, it is not part of this specific recall action. Alongside the REF number, you need to check the Software Version installed on the system. The recall applies exclusively to units running Paragonix App Ver. 6.1.1 or Paragonix App Ver. 6.1.2. If your device is running a different version of the software, it is not affected by this firmware defect.
The most definitive way to confirm if your unit is included in this recall is by checking the Unique Device Identifier (UDI) or Serial Number. The FDA notice specifies that the recall covers units with the UDI/Serial number 00850005470342. It is important to note that the official record lists only this specific identifier. While manufacturers often produce batches of devices, the current recall documentation does not explicitly state that all KidneyVault systems are affected—only those matching the specific reference and software criteria above, and specifically citing this serial number in the provided facts. If you have a different serial number, you should contact Paragonix Technologies Inc. directly to confirm its status, as the provided text does not list other serial numbers as part of this recall.
Regarding where these devices were sold, the distribution pattern indicates that these units were distributed nationwide across many U.S. states and territories, including Alabama, Arizona, California, Florida, New York, Texas, and others listed in the official notice. However, simply knowing that a device was sold in one of these locations is not enough to determine if your unit is recalled. You must rely on the specific hardware and software identifiers mentioned above. If you have lost the original packaging or documentation, look for the label on the device itself. Do not rely on approximate dates of purchase or general descriptions; the firmware defect is tied strictly to the software versions 6.1.1 and 6.1.2. If your unit does not match these exact specifications, it is likely safe from this particular issue, but always consult with Paragonix Technologies Inc. for final confirmation.
What to do — step by step
If you are involved with the Paragonix Technologies Inc. KidneyVault Portable Renal Perfusion System, specifically the unit identified by REF# PRGNX-8008-001, your immediate priority must be patient safety and device integrity. Because this is a Class II medical device recall involving a critical organ preservation tool used in transplant procedures, you cannot treat this situation casually. The recalled units contain a firmware defect that can cause the datalogger to lose its configuration, leading to a blank screen and the loss of displayed preservation parameters. This is not merely an inconvenience; it is a potential failure point in a life-saving process. However, there is a significant gap in the current public information: the FDA recall notice does not state the specific remedy for this recall. It does not explicitly instruct users to return the device, send it for repair, or issue a refund at this time. Because the official guidance is silent on the exact corrective action, you must take proactive steps to ensure you are not acting on outdated or incorrect information.
First and foremost, you must stop using any affected unit immediately if there is any indication that the firmware version is Paragonix App Ver. 6.1.1 or 6.1.2. Do not attempt to power cycle the device in hopes that it will reset itself, as the defect is inherent to the software configuration. A blank screen during a renal perfusion procedure could lead to a complete loss of monitoring data for the organ being preserved, which poses a severe risk to the viability of the kidney and, by extension, the recipient’s health. Your clinical team should have established protocols for backup monitoring or alternative preservation methods in case of equipment failure; activate those now. Do not rely on the device’s display if it has gone blank.
Next, you need to verify your inventory against the specific parameters of the recall. The affected units are distributed nationwide across states and territories including Alabama, Arizona, California, Tennessee, Florida, Hawaii, Minnesota, New Jersey, Texas, Utah, Colorado, Connecticut, Washington D.C., Maryland, Georgia, Kentucky, Louisiana, Massachusetts, Michigan, Missouri, Mississippi, North Carolina, North Dakota, Nebraska, New Mexico, Nevada, New York, Pennsylvania, Puerto Rico, South Carolina, Virginia, Wisconsin, West Virginia, Indiana, Ohio, Illinois, and Oregon. If your facility is in one of these regions, conduct a physical audit. Check the serial numbers and Unique Device Identifiers (UDI) for any unit matching 00850005470342. Document every unit that matches these criteria with photographs and written logs.
Because the remedy is not stated in the recall announcement, you must contact Paragonix Technologies Inc. directly to determine their specific instructions. It is highly likely that they will issue a firmware update or a hardware replacement, but you cannot assume this until you have spoken with their support team. Do not attempt to install unofficial software patches or third-party fixes, as this could void warranties or further compromise the device’s safety profile. Keep the affected devices in a secure, controlled environment where they cannot be accidentally used again. Label them clearly as “Recalled – Do Not Use.”
Finally, monitor official FDA channels and Paragonix Communications for an update to the recall notice. The absence of a stated remedy suggests that the company may be preparing a detailed directive or that the recall is part of a larger, coordinated safety campaign. Until you receive direct instruction from the manufacturer or the FDA, assume that the device is unsafe for clinical use. Your responsibility is to ensure that no patient receives care based on the potential output of a device that may silently fail to display critical preservation parameters. Document all communications with Paragonix Technologies Inc. regarding this recall for your facility’s compliance records.
Your refund, repair, or replacement options
When a medical device like the KidneyVault Portable Renal Perfusion System is recalled, the most immediate question for healthcare providers and institutional buyers is often, "What happens next?" In this specific case involving Paragonix Technologies Inc., the official recall documentation filed with the U.S. Food and Drug Administration (FDA) on July 20, 2026, presents a situation that requires careful attention to detail regarding the remedy. It is important to state clearly and honestly that the current recall notice does not explicitly outline a standardized remedy such as automatic refunds, direct repair services, or immediate replacement units. This absence of specific remediation instructions in the public record means that the path forward for those affected by this firmware defect depends heavily on direct communication with the manufacturer rather than an automated process.
The primary course of action for anyone holding a device under this recall is to contact Paragonix Technologies Inc. directly. While the recall facts do not provide a specific phone number or email address in the summary data, it is standard procedure for Class II device recalls to require users to reach out to the company’s customer support or quality assurance department to initiate any potential resolution. You should look for the most recent contact information provided on your device’s packaging, the original purchase invoice, or the official Paragonix website. When you make this call or send that email, have your device’s specific details ready. Specifically, ensure you can provide the Reference Number (REF# PRGNX-8008-001), the Software Version (Paragonix App Ver. 6.1.1 or 6.1.2), and the unique Serial Number/UDI (starting with 00850005470342). Having this information prepared will help the support team quickly verify whether your unit is part of the affected batch and determine what specific steps they are willing to take.
Because the hazard involves a firmware defect that causes the datalogger to lose its configuration, resulting in a blank screen and loss of displayed preservation parameters, the likely remedy will involve a software update or a firmware patch rather than a hardware replacement. However, this is an inference based on general medical device practices and not a stated fact in the recall notice. Do not assume you will receive a free repair or refund until Paragonix Technologies Inc. confirms it in writing. The company may offer to send updated software instructions for your clinical team to apply, or they may require the unit to be shipped back to them for servicing. It is crucial to follow whatever instruction set they provide exactly, as improper handling of medical device firmware can void warranties or create additional safety risks.
If you are a hospital administrator or procurement officer dealing with this recall across multiple units in states such as California, New York, Texas, Florida, or Massachusetts, do not attempt to resolve this through third-party vendors. The recall is specific to Paragonix Technologies Inc., and only they can authorize the official remedy. Keep detailed records of all communications with the manufacturer, including dates, names of representatives spoken to, and any case numbers provided. This documentation will be essential if you need to report adverse events or if there are discrepancies in how the remedy is delivered. Until you receive explicit guidance from Paragonix, treat the device as compromised and do not use it for its intended purpose of preserving organs during transfer.
What can happen if you ignore it
It is completely understandable to feel hesitant about stopping the use of a critical medical device, especially one as specialized as the KidneyVault Portable Renal Perfusion System. These devices are often relied upon for the delicate task of preserving vital organs during transport, and any interruption in workflow can cause anxiety. However, continuing to use the recalled Paragonix Technologies Inc. KidneyVault units (REF# PRGNX-8008-001) with software versions 6.1.1 or 6.1.2 carries significant and compounding risks that extend far beyond a simple inconvenience.
The core issue stems from a firmware defect that causes the device’s datalogger to lose its configuration. When this happens, the screen goes blank, and you lose access to all displayed preservation parameters. In the context of renal perfusion, these parameters are not just data points; they are the vital signs of the organ’s health. They typically include critical metrics such as temperature, pressure, flow rate, and solution composition. Without the ability to monitor these values in real-time, you are effectively operating the device blindly. You may believe the kidney is being perfused correctly, but without the visual confirmation provided by the screen, there is no way to know if the machine is malfunctioning, if the temperature has drifted outside safe limits, or if the flow has stopped entirely.
The consequences of this loss of visibility are profound for organ viability. Kidneys are highly sensitive organs that require precise environmental conditions to remain viable outside the body. If the perfusion solution becomes too warm, even by a small margin, cellular damage can begin rapidly. If the pressure is too high, it can damage the delicate blood vessels within the kidney; if it is too low, the organ may not receive adequate oxygenation. Ignoring the recall means accepting the risk that these conditions could deteriorate without your knowledge. By the time the problem is discovered—perhaps when the device finally powers down or when the organ is assessed at its destination—the damage to the tissue may already be irreversible.
Furthermore, this failure impacts the entire chain of care. A kidney that appears viable on arrival but has suffered microscopic ischemic injury due to unmonitored perfusion issues may fail shortly after transplantation. This not only jeopardizes the recipient’s health and survival but also wastes a precious, life-saving resource. Organ shortages are a critical national crisis, and every donated kidney is invaluable. Allowing a known defect to compromise the integrity of that organ undermines the efforts of donors, families, and the medical teams who work tirelessly to save lives.
While the FDA recall notice for this specific issue does not currently list any reported injuries or incidents, the potential for harm is inherent in the nature of the hazard. The blank screen creates a false sense of security. You might assume everything is fine because the device appears to be running, but the loss of configuration means the monitoring system itself has failed. Ignoring this defect turns a controlled medical procedure into an unmonitored gamble with outcomes that can range from organ rejection to graft failure. Taking action now is the only way to ensure that the organ remains in the condition necessary for a successful transplant.
Staying safe: broader tips
When dealing with complex medical or laboratory equipment like portable organ preservation systems, the most effective safety strategy extends far beyond checking for a single recall notice. These devices are critical components in high-stakes environments where precision and reliability are non-negotiable. To maintain the highest level of safety and operational integrity, it is essential to adopt a proactive approach to device management that prioritizes prevention, regular verification, and continuous education.
First, establish a rigorous routine for software and firmware updates. In the case of electronic medical devices, software defects—such as those causing configuration loss or screen failures—are often addressed through targeted patches released by the manufacturer. Do not wait for a public recall announcement to update your system. Instead, maintain direct communication with your vendor and monitor official channels like the FDA’s Medical Device Recall database regularly. Subscribe to alert services from the device manufacturer specifically for your model. This ensures that you are among the first to know when a firmware fix is available, allowing you to apply it before a minor glitch becomes a critical failure during use.
Second, implement a strict pre-use inspection protocol. Even with robust software, hardware issues can arise. Before every session, visually inspect your device for any signs of physical damage, loose connections, or unusual behavior. Check that all cables are secure and that the power source is stable. If your device has a self-diagnostic feature, run it daily. Treat these checks as non-negotiable parts of your workflow, similar to how you would check the sterility of surgical instruments. Documenting these checks in a logbook or digital record not only helps you track the device’s health over time but also provides valuable data for troubleshooting if an issue does occur.
Third, ensure that all users are thoroughly trained on both the normal operation and the emergency procedures of the device. Human error is a significant factor in equipment mishaps. Regular refresher training sessions can help staff recognize early warning signs, such as erratic readings or unexpected shutdowns, before they escalate into dangerous situations. Encourage a culture where team members feel comfortable reporting minor anomalies without fear of blame. Early reporting allows for corrective action to be taken proactively.
Finally, stay informed about broader safety trends in your field. Join professional associations and participate in online forums dedicated to your specific medical discipline. These communities often share insights about emerging risks, new best practices, and lessons learned from incidents elsewhere. By staying engaged with the wider professional community, you gain a deeper understanding of how to protect patients and ensure the reliability of the technology you rely on every day.